{
  "outputs": [
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Emergency Medicine",
      "unstructuredTopicList": "1.2025 ACC/AHA/ACEP Acute Coronary Syndromes Guideline 2. ACEP Reaffirms EMTALA Obligations Post-Guidance Rescission 3. Physician On-Site Requirement in ED (South Carolina Law) 4. VR + Music Relieves Acute Tension Headache (RCT) 5. FDA Approves Andembry (Garadacimab) for HAE Prophylaxis 6. FDA Approves Enflonsia (Clesrovimab) for Infant RSV Prevention 7. FDA Approves Yeztugo (Lenacapavir) – 6-Month HIV PrEP Injection 8. No Benefit of Thrombectomy in Medium Vessel Stroke (ESCAPE-MeVO Trial) 9. IV Iron Falls Short in Systolic Heart Failure (FAIR-HF2) 10. BedMed Trial: BP Meds Timing Doesn’t Matter 11. EAST Guideline on REBOA in Trauma 12. CDC Narrows COVID Vaccine Guidance – EM Concerns 13. Naloxone Nasal Spray Shelf-Life Extended to 4 Years 14. ACEP Clinical Policy: Carbon Monoxide Poisoning (2025) 15. Virtual Reality in Emergency Care Innovation"
    },
    {
      "isInSupabase": "false",
      "startDate": "2025-06-01",
      "specialty": "Emergency Medicine",
      "unstructuredTopicList": "2025 ACC/AHA/ACEP Guideline for Management of Acute Coronary Syndromes, 2. FLUID Trial – Lactated Ringer’s vs Normal Saline, 3. FDA Approval of Merck’s Enflonsia™ (Clesrovimab) for Infant RSV, 4. OPTPRESS Trial – High vs Standard MAP in Septic Shock, 5. Azithromycin vs Doxycycline for CAP in Hospital, 6. EAST Guideline on REBOA for Hemorrhagic Shock, 7. No Benefit for Thrombectomy in Distal Stroke Occlusions, 8. EAST “Trauma in Pregnancy” Guidelines, 9. Post–Cardiac Arrest Oxygen & CO₂ Targets, 10. FDA Approval of Brekiya™ (DHE Autoinjector) for Migraine/Cluster, 11. Point-of-Care High-Sensitivity Troponin RCT, 12. ASH/ISTH Updated Pediatric VTE Guidelines, 13. Normal Saline vs Lactated Ringer’s in Pediatric DKA, 14. Pharmacist Intervention in ED (URGEIM Trial), 15. Inhaled Albuterol for Renal Colic Pain."
    }
  ]
}
